Midlife and late-life obesity and the risk of dementia: cardiovascular health study - PubMed (original) (raw)
Midlife and late-life obesity and the risk of dementia: cardiovascular health study
Annette L Fitzpatrick et al. Arch Neurol. 2009 Mar.
Abstract
Background: While high adiposity in middle age appears to be related to greater dementia risk, studies exploring this association in the elderly are conflicting.
Objective: To evaluate associations between midlife and late-life obesity and risk of dementia.
Design: Prospective study with mean follow-up of 5.4 years (1992-1994 through 1999).
Setting: Community-dwelling sample in 4 US sites recruited from Medicare eligibility files.
Participants: A total of 2798 adults without dementia (mean age, 74.7 years; 59.1% women) participating in the Cardiovascular Health Study who underwent magnetic resonance imaging were measured for height and weight at baseline at age 65 years or older (late life), and self-reported weight at age 50 years (midlife). Body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) was calculated at both times.
Main outcome measures: Dementia, Alzheimer disease, and vascular dementia classified by a multidisciplinary committee using standardized criteria.
Results: Classification resulted in 480 persons with incident dementia, 245 with Alzheimer disease (no vascular dementia), and 213 with vascular dementia (with or without Alzheimer disease). In evaluations of midlife obesity, an increased risk of dementia was found for obese (BMI >30) vs normal-weight (BMI 20-25) persons, adjusted for demographics (hazard ratio [HR], 1.39; 95% confidence interval [CI], 1.03-1.87) and for cardiovascular risk factors (1.36; 0.94-1.95). The risk estimates were reversed in assessments of late-life BMI. Underweight persons (BMI <20) had an increased risk of dementia (1.62; 1.02-2.64), whereas being overweight (BMI >25-30) was not associated (0.92; 0.72-1.18) and being obese reduced the risk of dementia (0.63; 0.44-0.91) compared with those with normal BMI.
Conclusion: These results help explain the "obesity paradox" as differences in dementia risk across time are consistent with physical changes in the trajectory toward disability.
Figures
Figure 1
Risk of dementia by BMI at mid-life (age 50).
Figure 2
Risk of dementia by BMI at late-life (age 65 or older).
Similar articles
- Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.
Anstey KJ, Cherbuin N, Budge M, Young J. Anstey KJ, et al. Obes Rev. 2011 May;12(5):e426-37. doi: 10.1111/j.1467-789X.2010.00825.x. Epub 2011 Feb 23. Obes Rev. 2011. PMID: 21348917 Review. - Association of Body Mass Index in Late Life, and Change from Midlife to Late Life, With Incident Dementia in the ARIC Study Participants.
Cannon EJ, Windham BG, Griswold M, Palta P, Knopman DS, Sedaghat S, Lutsey PL. Cannon EJ, et al. Neurology. 2025 May 13;104(9):e213534. doi: 10.1212/WNL.0000000000213534. Epub 2025 Apr 11. Neurology. 2025. PMID: 40215425 - Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort.
Tolppanen AM, Ngandu T, Kåreholt I, Laatikainen T, Rusanen M, Soininen H, Kivipelto M. Tolppanen AM, et al. J Alzheimers Dis. 2014;38(1):201-9. doi: 10.3233/JAD-130698. J Alzheimers Dis. 2014. PMID: 23948937 - Body mass index in midlife and risk of Alzheimer disease and vascular dementia.
Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Whitmer RA, et al. Curr Alzheimer Res. 2007 Apr;4(2):103-9. doi: 10.2174/156720507780362047. Curr Alzheimer Res. 2007. PMID: 17430231 - 2003-2013: a decade of body mass index, Alzheimer's disease, and dementia.
Emmerzaal TL, Kiliaan AJ, Gustafson DR. Emmerzaal TL, et al. J Alzheimers Dis. 2015;43(3):739-55. doi: 10.3233/JAD-141086. J Alzheimers Dis. 2015. PMID: 25147111 Review.
Cited by
- Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.
Waragai M, Ho G, Takamatsu Y, Wada R, Sugama S, Takenouchi T, Masliah E, Hashimoto M. Waragai M, et al. J Alzheimers Dis. 2020;76(4):1249-1253. doi: 10.3233/JAD-200416. J Alzheimers Dis. 2020. PMID: 32623396 Free PMC article. - Effects of Dietary Methionine Restriction on Cognition in Mice.
Lail H, Mabb AM, Parent MB, Pinheiro F, Wanders D. Lail H, et al. Nutrients. 2023 Nov 29;15(23):4950. doi: 10.3390/nu15234950. Nutrients. 2023. PMID: 38068808 Free PMC article. Review. - Associations of body mass index and sarcopenia with screen-detected mild cognitive impairment in older adults in Colombia.
O'Donovan G, Sarmiento OL, Hessel P, Muniz-Terrera G, Duran-Aniotz C, Ibáñez A. O'Donovan G, et al. Front Nutr. 2022 Oct 18;9:1011967. doi: 10.3389/fnut.2022.1011967. eCollection 2022. Front Nutr. 2022. PMID: 36330135 Free PMC article. - Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease.
Christensen A, Pike CJ. Christensen A, et al. Front Aging Neurosci. 2015 Jul 7;7:130. doi: 10.3389/fnagi.2015.00130. eCollection 2015. Front Aging Neurosci. 2015. PMID: 26217222 Free PMC article. Review. - Body mass index and cognitive function: the potential for reverse causation.
Suemoto CK, Gilsanz P, Mayeda ER, Glymour MM. Suemoto CK, et al. Int J Obes (Lond). 2015 Sep;39(9):1383-9. doi: 10.1038/ijo.2015.83. Epub 2015 May 8. Int J Obes (Lond). 2015. PMID: 25953125 Free PMC article.
References
- Knowler WC, Narayan KM, Hanson RL, et al. Preventing non-insulin-dependent diabetes. Diabetes. 1995;44:483–488. - PubMed
- Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998;21(Suppl 3):C11–14. - PubMed
- Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518–524. - PubMed
- Mann J. Stemming the tide of diabetes mellitus. Lancet. 2000;356:1454–1455. - PubMed
Publication types
MeSH terms
Grants and funding
- N01 HC085080/HL/NHLBI NIH HHS/United States
- N01-HC-85085/HC/NHLBI NIH HHS/United States
- N01-HC-85081/HC/NHLBI NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- N01HC-55222/HC/NHLBI NIH HHS/United States
- N01-HC-85082/HC/NHLBI NIH HHS/United States
- 5 R01 AG15928-02/AG/NIA NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- N01HC-15103/HC/NHLBI NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- U01HL080295/HL/NHLBI NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
- R01 AG015928/AG/NIA NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC085083/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01-HC-85083/HC/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01-HC-85080/HC/NHLBI NIH HHS/United States
- N01 HC085081/HL/NHLBI NIH HHS/United States
- N01-HC-85084/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical